C07K 14/785
Alveolar surfactant peptides
Official title: Alveolar surfactant peptides; Pulmonary surfactant peptides
C07K14/785 (Alveolar surfactant peptides) appears on 110 US grants and 99 published applications in this corpus.
Search patents in C07K- Granted patents
- 110
- Published applications
- 99
- Assignees
- 73
- Inventors
- 241
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 1 |
| 2003 | 3 | 6 |
| 2004 | 0 | 2 |
| 2005 | 2 | 3 |
| 2006 | 3 | 4 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 2 | 6 |
| 2010 | 2 | 2 |
| 2011 | 3 | 4 |
| 2012 | 6 | 5 |
| 2013 | 3 | 7 |
| 2014 | 5 | 7 |
| 2015 | 3 | 6 |
| 2016 | 4 | 5 |
| 2017 | 3 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 7 |
| 2020 | 4 | 4 |
| 2021 | 2 | 8 |
| 2022 | 2 | 1 |
| 2023 | 0 | 5 |
| 2024 | 0 | 4 |
| 2025 | 4 | 5 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polypeptides having improved properties21 Apr 2026US 12,606,609 B2Chiesi Farmaceutici S.P. A.
- Methods and compositions comprising surfactant protein D (SP-D)9 Dec 2025US 12,491,234 B2Airway Therapeutics, Inc.
- Methods, compositions and cells for preparing surfactant protein D (SP-D)19 Aug 2025US 12,391,956 B2Airway Therapeutics, Inc.
- Systems and methods for characterizing surfactant protein D (SP-D) oligomers12 Aug 2025US 12,385,894 B2Airway Therapeutics, Inc.
- Nanocarriers for lung inflammation therapy11 Feb 2025US 12,221,471 B2Ohio State Innovation Foundation
- Methods for Treating Premature Newborn Infants by Administration of Recombinant Human Surfactant Protein D (rhSP-D)20 Aug 2026US 2026/0240946 A1Airway Therapeutics, Inc.
- Fusion protein comprising a surfactant-protein-d and a member of the tnfsf15 Jan 2026US 2026/0015405 A1Transgene S. A.
- Synthetic lung surfactant with enhanced stability and effectiveness25 Sep 2025US 2025/0296981 A1Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Surfactant Formulations for Inhalation18 Sep 2025US 2025/0288516 A1Merz Pharmaceuticals, LLC
- Multivalent display on enveloped particles with human oligomerization domains18 Sep 2025US 2025/0288662 A1Achelois Biopharma, Inc.
Most cited
By later US patents
- Fire extinguishing agent and fire extinguishing method using same64US 9,776,029 B2Kaneka Corporation · 2017
- Fused protein for enzyme immunoassay system62US 4,745,055 ACalifornia Biotechnology Inc. · 1988
- Pulmonary surfactant protein fragments59US 5,302,581 AAbbott Laboratories · 1994
- Superior mammalian expression system43US 5,089,397 ACalifornia Biotechnology Inc. · 1992
- Synthetic pulmonary surfactant33US 4,861,756 AMerrell Dow Pharmaceuticals Inc. · 1989